Mylan Gets OK To Appeal Neurim Win Over Circadin Patent
An appellate court on Tuesday gave generic drugmaker Mylan another shot at challenging a patent for an insomnia drug held by Neurim Pharmaceuticals, saying the lower court did not properly consider...To view the full article, register now.
Already a subscriber? Click here to view full article